Description
An angiogenesis inhibitor with anticancer activity; inhibits bFGF- and VEGF-stimulated HUVEC proliferation (IC50s = 0.1 and 0.081 μg/ml, respectively); inhibits bFGF- and VEGF-stimulated tube formation of HUVECs (IC50s = 0.2 and 0.24 μg/ml, respectively); selectively decreases the surface expression and mRNA levels of integrin α2 over CD31 and VE-cadherin in HUVECs; reduces tumor growth and inhibits angiogenesis in a WiDr colorectal cancer mouse xenograft model at 200 and 400 mg/kg; reduces tumor weight in a panel of seven human colon, breast, pancreas, and kidney cancer mouse xenograft models; completely inhibits tumor growth in KP-1 pancreatic and LoVo colon cancer mouse xenograft models; inhibits tumor growth in KP-1 and COLO 320DM mouse orthotopic transplantation models,
Formal name: 3-cyano-N-(3-cyano-4-methyl-1H-indol-7-yl)-benzenesulfonamide
Synonyms:
Molecular weight: 336.4
CAS: 289483-69-8
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals||Research Area|Cancer|Angiogenesis